Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Titles
NEW
 Top 50 Non-Healthcare Titles
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Cancer Immunotherapy Drug Discovery Outsourcing Global Market Report 2025
Request Sample Buy Now
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Cancer Immunotherapy Drug Discovery Outsourcing Global Market Report 2025

By Drug Type (Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies And Cancer Vaccines, Other Drug Types), By Service Type (Target Identification And Validation, Lead Screening And Characterization, Cell-based Assays), By Therapeutic Area (Lung Cancer, Breast Cancer, Melanoma, Other Therapeutic Areas) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Cancer Immunotherapy Drug Discovery Outsourcing Market Overview

• Cancer Immunotherapy Drug Discovery Outsourcing market size has reached to $1.5 billion in 2024

• Expected to grow to $2.45 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%

• Growth Driver: High R&D Costs Fueling Growth in Cancer Immunotherapy Drug Discovery Outsourcing Market

• Market Trend: Strategic Partnerships Driving Cancer Immunotherapy Drug Discovery Outsourcing

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cancer Immunotherapy Drug Discovery Outsourcing Market?

Cancer immunotherapy drug discovery outsourcing is a specialized service model in the pharmaceutical and biotech sectors. It entails delegating aspects of cancer immunotherapy drug development to external service providers, typically contract research organizations (CROs) or contract development and manufacturing organizations (CDMOs) to speeds up innovation by leveraging external expertise and resources, letting pharmaceutical companies focus on core activities.

The main drug types of cancer immunotherapy drug discovery outsourcing are monoclonal antibodies, immunomodulators, oncolytic viral therapies and cancer vaccines, and others. Monoclonal antibodies refers to laboratory-made molecules that mimic the immune system's ability to fight off harmful pathogens by targeting specific proteins on cancer cells. The services include target identification and validation, lead screening and characterization, and cell-based assays used in therapeutic areas such as lung cancer, breast cancer, melanoma, and others.

Cancer Immunotherapy Drug Discovery Outsourcing Market Size and growth rate 2025 to 2029: Graph

What Is The Cancer Immunotherapy Drug Discovery Outsourcing Market Size 2025 And Growth Rate?

The cancer immunotherapy drug discovery outsourcing market size has grown rapidly in recent years. It will grow from $1.5 billion in 2024 to $1.66 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to increasing cases of adverse drug reactions, increasing demand for comprehensive genomic testing, increasing global incidence of cancer, a growing need for targeted therapy, and a growing number of clinical trials.

What Is The Cancer Immunotherapy Drug Discovery Outsourcing Market Growth Forecast?

The cancer immunotherapy drug discovery outsourcing market size is expected to see rapid growth in the next few years. It will grow to $2.45 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to the rising importance of personalized medicine, increasing diagnostic tests, increasing focus on personalized cancer therapy, increasing healthcare expenditure, and increasing cancer incidence and awareness. Major trends in the forecast period include advancements in diagnostic technologies, next-generation sequencing (NGS), integration of artificial intelligence (AI), liquid biopsy technologies, the development of point-of-care companion diagnostic devices, and innovative testing technologies.

The forecast of 10.2% growth over the next five years reflects a modest reduction of 1.1% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. biotech firms by driving up costs of cancer immunotherapy drug discovery services outsourced to India and China, exacerbating R&D expenses and increasing oncology innovation timelines. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Cancer Immunotherapy Drug Discovery Outsourcing Market Segmented?

1) By Drug Type: Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies And Cancer Vaccines, Other Drug Types

2) By Service Type: Target Identification And Validation, Lead Screening And Characterization, Cell-Based Assays

3) By Therapeutic Area: Lung Cancer, Breast Cancer, Melanoma, Other Therapeutic Areas

Subsegments:

1) By Monoclonal Antibodies: checkpoint inhibitors, Therapeutic Monoclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates (ADCs)

2) By Immunomodulators: Cytokines, Immune Checkpoint Modulators, Toll-Like Receptor Agonists, Immune Adjuvants

3) By Oncolytic Viral Therapies And Cancer Vaccines: Oncolytic Virus-Based Therapies, Cancer Vaccines, Viral Vectors For Immunotherapy

4) By Other Drug Types: Adoptive Cell Therapy, Immune Cell Modulators, Small Molecule Immune Modulators, Gene Editing And Immunotherapy

What Is Driving The Cancer Immunotherapy Drug Discovery Outsourcing Market? High R&D Costs Fueling Growth in Cancer Immunotherapy Drug Discovery Outsourcing Market

The high cost of research and development is expected to propel the growth of the cancer immunotherapy drug discovery outsourcing market going forward. The high cost research and development is primarily due to the need for specialized expertise, expensive equipment, and the inherent risks involved in innovation. Outsourcing drug discovery activity leverages economies of scale offered by contract research organizations (CROs), enabling smaller biotech firms and startups to optimize their R&D budgets and allocate resources more efficiently, enhancing cost-effectiveness. For instance, in June 2023, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a European trade association representing the pharmaceutical industry, the total pharmaceutical R&D expenditure in Europe accounted for $49,500 million (€44,500 million) in 2022, an increase of approximately 6.45% from $46,500 million (€42,533 million) in 2021. Therefore, the high cost of in-house research and development is driving the growth of the cancer immunotherapy drug discovery outsourcing industry.

Who Are The Major Players In The Global Cancer Immunotherapy Drug Discovery Outsourcing Market?

Major companies operating in the cancer immunotherapy drug discovery outsourcing market are Thermo Fisher Scientific Inc., Danaher Corporation, Laboratory Corporation of America Holdings (LabCorp), Eurofins Scientific SE, WuXi AppTec Co Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Evotec SE, Shanghai ChemPartner Co. Ltd., Aragen Life Sciences Limited, GenScript Biotech Corporation, BGI Genomics Co. Ltd., NeoGenomics Laboratories Inc., ARUP Laboratories, Syngene International Limited, BioDuro-Sundia, Ambry Genetics Corporation, Selvita, Crown Bioscience International, CENTOGENE N.V., Jubilant Biosys, Oncodesign Services, Icagen Inc., Reaction Biology Corporation, ChemBridge Corporation

What Are The Key Trends Of The Global Cancer Immunotherapy Drug Discovery Outsourcing Market? Strategic Partnerships Driving Cancer Immunotherapy Drug Discovery Outsourcing

Major companies operating in the cancer immunotherapy drug discovery outsourcing market are adopting a strategic partnership approach to support the production of cancer drugs and gain a competitive advantage. A strategic partnership typically refers to a collaborative relationship between two or more organizations where they combine their resources, expertise, and efforts to achieve common goals or objectives. For instance, in February 2022, Ono Pharmaceutical Co., Ltd., a Japan-based pharmaceutical company, and Bristol-Myers Squibb, a US-based biopharmaceutical company, entered into an outsourcing agreement with Prime Research Institute for Medical Research, Inc., a Japan-based research institute, for a collaborative clinical research project focused on gastric cancer patients treated with Opdivo (nivolumab) in combination with chemotherapy. This industry-sponsored initiative involves a large-scale, multi-institutional study utilizing PRiME-R's data input support system called CyberOncology, which facilitates the standardization, structuring, management, and integration of real-world data in routine cancer clinical practice. This clinical research, utilizing CyberOncology, evaluates Opdivo combined with chemotherapy for untreated advanced or recurrent gastric cancer. It involves about 30 medical institutions nationwide and aims to streamline data input, enhance data accuracy, and expedite analysis.

Need data on a specific region in this market?
Request Customisation

What Are Latest Mergers And Acquisitions In The Cancer Immunotherapy Drug Discovery Outsourcing Market? Collaboration Between Ono Pharmaceutical And Bristol Myers Squibb For Advanced Gastric Cancer Research

In February 2022, Ono Pharmaceutical Co.Ltd, a Japan-based pharmaceutical company, collaborated with Bristol Myers Squibb K.K. This collaboration aims to conduct a large-scale, multi-institutional clinical research study on the efficacy and safety of Opdivo (nivolumab) in combination with chemotherapy for patients with advanced or recurrent gastric cancer. This initiative utilizes PRIMER's CyberOncology system, which standardizes and integrates real-world data from clinical practice, thereby enhancing the accuracy and efficiency of the research process. Bristol Myers Squibb K.K. is a US-based multinational biopharmaceutical company.

What Is The Regional Outlook For The Global Cancer Immunotherapy Drug Discovery Outsourcing Market?

North America was the largest region in the cancer immunotherapy drug discovery outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cancer Immunotherapy Drug Discovery Outsourcing Market?

The cancer immunotherapy drug discovery outsourcing market includes revenues earned by entities by providing services such as preclinical testing, clinical trial support, and biomarker discovery. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Cancer Immunotherapy Drug Discovery Outsourcing Industry?

The cancer immunotherapy drug discovery outsourcing market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cancer immunotherapy drug discovery outsourcing industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Cancer Immunotherapy Drug Discovery Outsourcing Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $1.66 billion
Revenue Forecast In 2034 $2.45 billion
Growth Rate CAGR of 10.2% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Drug Type: Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies And Cancer Vaccines, Other Drug Types
2) By Service Type: Target Identification And Validation, Lead Screening And Characterization, Cell-Based Assays
3) By Therapeutic Area: Lung Cancer, Breast Cancer, Melanoma, Other Therapeutic Areas Subsegments: 1) By Monoclonal Antibodies: Checkpoint Inhibitors, Therapeutic Monoclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates (ADCs)
2) By Immunomodulators: Cytokines, Immune Checkpoint Modulators, Toll-Like Receptor Agonists, Immune Adjuvants
3) By Oncolytic Viral Therapies And Cancer Vaccines: Oncolytic Virus-Based Therapies, Cancer Vaccines, Viral Vectors For Immunotherapy
4) By Other Drug Types: Adoptive Cell Therapy, Immune Cell Modulators, Small Molecule Immune Modulators, Gene Editing And Immunotherapy
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Thermo Fisher Scientific Inc., Danaher Corporation, Laboratory Corporation of America Holdings (LabCorp), Eurofins Scientific SE, WuXi AppTec Co Ltd., Charles River Laboratories International Inc., PerkinElmer Inc, Bio-Rad Laboratories Inc, QIAGEN N.V., Evotec SE, Shanghai ChemPartner Co. Ltd., Aragen Life Sciences Limited, GenScript Biotech Corporation, BGI Genomics Co. Ltd., NeoGenomics Laboratories Inc, ARUP Laboratories, Syngene International Limited, BioDuro-Sundia, Ambry Genetics Corporation, Selvita, Crown Bioscience International, CENTOGENE N.V., Jubilant Biosys, Oncodesign Services, Icagen Inc., Reaction Biology Corporation, ChemBridge Corporation
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Cancer Immunotherapy Drug Discovery Outsourcing Market Characteristics

3. Cancer Immunotherapy Drug Discovery Outsourcing Market Trends And Strategies

4. Cancer Immunotherapy Drug Discovery Outsourcing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cancer Immunotherapy Drug Discovery Outsourcing Growth Analysis And Strategic Analysis Framework

5.1. Global Cancer Immunotherapy Drug Discovery Outsourcing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Growth Rate Analysis

5.4. Global Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Cancer Immunotherapy Drug Discovery Outsourcing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Cancer Immunotherapy Drug Discovery Outsourcing Total Addressable Market (TAM)

6. Cancer Immunotherapy Drug Discovery Outsourcing Market Segmentation

6.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Monoclonal Antibodies

Immunomodulators

Oncolytic Viral Therapies And Cancer Vaccines

Other Drug Types

6.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Target Identification And Validation

Lead Screening And Characterization

Cell-Based Assays

6.3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Lung Cancer

Breast Cancer

Melanoma

Other Therapeutic Areas

6.4. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Checkpoint Inhibitors

Therapeutic Monoclonal Antibodies

Bispecific Antibodies

Antibody-Drug Conjugates (ADCs)

6.5. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub-Segmentation Of Immunomodulators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cytokines

Immune Checkpoint Modulators

Toll-Like Receptor Agonists

Immune Adjuvants

6.6. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub-Segmentation Of Oncolytic Viral Therapies And Cancer Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oncolytic Virus-Based Therapies

Cancer Vaccines

Viral Vectors For Immunotherapy

6.7. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Adoptive Cell Therapy

Immune Cell Modulators

Small Molecule Immune Modulators

Gene Editing And Immunotherapy

7. Cancer Immunotherapy Drug Discovery Outsourcing Market Regional And Country Analysis

7.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market

8.1. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cancer Immunotherapy Drug Discovery Outsourcing Market

9.1. China Cancer Immunotherapy Drug Discovery Outsourcing Market Overview

9.2. China Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cancer Immunotherapy Drug Discovery Outsourcing Market

10.1. India Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market

11.1. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Overview

11.2. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market

12.1. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cancer Immunotherapy Drug Discovery Outsourcing Market

13.1. Indonesia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market

14.1. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market Overview

14.2. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cancer Immunotherapy Drug Discovery Outsourcing Market

15.1. Western Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Overview

15.2. Western Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cancer Immunotherapy Drug Discovery Outsourcing Market

16.1. UK Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market

17.1. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cancer Immunotherapy Drug Discovery Outsourcing Market

18.1. France Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market

19.1. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cancer Immunotherapy Drug Discovery Outsourcing Market

20.1. Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cancer Immunotherapy Drug Discovery Outsourcing Market

21.1. Eastern Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Overview

21.2. Eastern Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cancer Immunotherapy Drug Discovery Outsourcing Market

22.1. Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cancer Immunotherapy Drug Discovery Outsourcing Market

23.1. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Overview

23.2. North America Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cancer Immunotherapy Drug Discovery Outsourcing Market

24.1. USA Cancer Immunotherapy Drug Discovery Outsourcing Market Overview

24.2. USA Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market

25.1. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market Overview

25.2. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cancer Immunotherapy Drug Discovery Outsourcing Market

26.1. South America Cancer Immunotherapy Drug Discovery Outsourcing Market Overview

26.2. South America Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market

27.1. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market

28.1. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market Overview

28.2. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market

29.1. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Overview

29.2. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cancer Immunotherapy Drug Discovery Outsourcing Market Competitive Landscape And Company Profiles

30.1. Cancer Immunotherapy Drug Discovery Outsourcing Market Competitive Landscape

30.2. Cancer Immunotherapy Drug Discovery Outsourcing Market Company Profiles

30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Laboratory Corporation of America Holdings (LabCorp) Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

30.2.5. WuXi AppTec Co Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Cancer Immunotherapy Drug Discovery Outsourcing Market Other Major And Innovative Companies

31.1. Charles River Laboratories International Inc.

31.2. PerkinElmer Inc

31.3. Bio-Rad Laboratories Inc

31.4. QIAGEN N.V.

31.5. Evotec SE

31.6. Shanghai ChemPartner Co. Ltd.

31.7. Aragen Life Sciences Limited

31.8. GenScript Biotech Corporation

31.9. BGI Genomics Co. Ltd.

31.10. NeoGenomics Laboratories Inc

31.11. ARUP Laboratories

31.12. Syngene International Limited

31.13. BioDuro-Sundia

31.14. Ambry Genetics Corporation

31.15. Selvita

32. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cancer Immunotherapy Drug Discovery Outsourcing Market

34. Recent Developments In The Cancer Immunotherapy Drug Discovery Outsourcing Market

35. Cancer Immunotherapy Drug Discovery Outsourcing Market High Potential Countries, Segments and Strategies

35.1 Cancer Immunotherapy Drug Discovery Outsourcing Market In 2029 - Countries Offering Most New Opportunities

35.2 Cancer Immunotherapy Drug Discovery Outsourcing Market In 2029 - Segments Offering Most New Opportunities

35.3 Cancer Immunotherapy Drug Discovery Outsourcing Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub-Segmentation Of Immunomodulators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub-Segmentation Of Oncolytic Viral Therapies And Cancer Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Thermo Fisher Scientific Inc. Financial Performance
  • Table 79: Danaher Corporation Financial Performance
  • Table 80: Laboratory Corporation of America Holdings (LabCorp) Financial Performance
  • Table 81: Eurofins Scientific SE Financial Performance
  • Table 82: WuXi AppTec Co Ltd. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub-Segmentation Of Immunomodulators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub-Segmentation Of Oncolytic Viral Therapies And Cancer Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 79: Danaher Corporation Financial Performance
  • Figure 80: Laboratory Corporation of America Holdings (LabCorp) Financial Performance
  • Figure 81: Eurofins Scientific SE Financial Performance
  • Figure 82: WuXi AppTec Co Ltd. Financial Performance

Emerging Trends and Growth Drivers in the Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Through 2029

Read More About Emerging Trends and Growth Drivers in the Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Through 2029

Global Leukemia Inhibitory Factor (LIF) Market Landscape: Trends and Market Share to 2029

Read More About Global Leukemia Inhibitory Factor (LIF) Market Landscape: Trends and Market Share to 2029

2025 Medical Amino Acid Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Read More About 2025 Medical Amino Acid Market Outlook: Opportunities, Growth Trends, and Strategic Analysis

Industry Trends Show Medicated Skincare Market Set to Expand at 6.6% CAGR Until 2029

Read More About Industry Trends Show Medicated Skincare Market Set to Expand at 6.6% CAGR Until 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Read More About A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Sailboat Market 2023 – By Hull Type (Monohull, Multi-Hull), By Length (Up To 20 ft, 20-50 ft, Above 50 ft), By Application (Recreation, Racing, Sail Training), And By Region, Opportunities And Strategies – Global Forecas...

View Report

Blood Cancer Drugs Global Market Report 2025 – By Blood Cancer Type (Leukemia, Lymphoma), By Drugs (Rituxan/Mabthera (Rituximab), Gleevec/Glivec (Imatinib), Revlimid (Lenalidomide), Velcade (Bortezomib), Tasigna (Nilotin...

View Report

Bladder Cancer Drugs Global Market Report 2025 – By Type (Non-Muscle-Invasive Bladder Cancer, Muscle-Invasive Bladder Cancer), By Application (Low-Grade Tumors, High-Grade Tumors), By Distribution Channel (Hospital Pharm...

View Report

Crohn's Disease (CD) Treatment Global Market Report 2025 – By Drug Type (Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types), By Route of Administration (Oral, Injectable), By Distributio...

View Report

Pediatric Neurology Device Global Market Report 2025 – By Product Type (Neurostimulation Devices, Neurosurgery Devices, Interventional Neurology Devices, Cerebrospinal Fluid Management Devices, Other Types), By Condition...

View Report

Breast Cancer Monoclonal Antibodies Global Market Report 2025 – By Product (Naked Mabs, Conjugated Mabs), By Treatment (Chemotherapy, Surgery & Radiation Therapy, Targeted Therapy, Biologic Therapy, Hormone Therapy), By ...

View Report

Breast Cancer Drugs Global Market Report 2025 – By Type (Metastatic Breast Cancer, Triple Negative Breast Cancer, Others (Ductal Carcinoma Insitu, Invasive Ductal Carcinoma, Inflammatory Breast Cancer, Breast Cancer Duri...

View Report

Breast Cancer Diagnostics Global Market Report 2025 – By Type (Imaging, Biopsy, Genomic Tests, Blood Tests, Other Types), By Technology (Fluorescent In Situ Hybridization (FISH), Comparative Genomic Hybridization (CGH), ...

View Report

Frequently Asked Questions

Cancer immunotherapy drug discovery outsourcing is a specialized service model in the pharmaceutical and biotech sectors. It entails delegating aspects of cancer immunotherapy drug development to external service providers, typically contract research organizations (CROs) or contract development and manufacturing organizations (CDMOs) to speeds up innovation by leveraging external expertise and resources, letting pharmaceutical companies focus on core activities. For further insights on this market, request a sample here

The market major growth driver - High R&D Costs Fueling Growth in Cancer Immunotherapy Drug Discovery Outsourcing Market. For further insights on this market, request a sample here

The cancer immunotherapy drug discovery outsourcing market size has grown rapidly in recent years. It will grow from $1.5 billion in 2024 to $1.66 billion in 2025 at a compound annual growth rate (CAGR) of 10.6%. The growth in the historic period can be attributed to increasing cases of adverse drug reactions, increasing demand for comprehensive genomic testing, increasing global incidence of cancer, a growing need for targeted therapy, and a growing number of clinical trials. The cancer immunotherapy drug discovery outsourcing market size is expected to see rapid growth in the next few years. It will grow to " $2.45 billion in 2029 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to the rising importance of personalized medicine, increasing diagnostic tests, increasing focus on personalized cancer therapy, increasing healthcare expenditure, and increasing cancer incidence and awareness. Major trends in the forecast period include advancements in diagnostic technologies, next-generation sequencing (NGS), integration of artificial intelligence (AI), liquid biopsy technologies, the development of point-of-care companion diagnostic devices, and innovative testing technologies. For further insights on this market, request a sample here

The cancer immunotherapy drug discovery outsourcing market covered in this report is segmented –
1) By Drug Type: Monoclonal Antibodies, Immunomodulators, Oncolytic Viral Therapies And Cancer Vaccines, Other Drug Types
2) By Service Type: Target Identification And Validation, Lead Screening And Characterization, Cell-Based Assays
3) By Therapeutic Area: Lung Cancer, Breast Cancer, Melanoma, Other Therapeutic Areas Subsegments:
1) By Monoclonal Antibodies: Checkpoint Inhibitors, Therapeutic Monoclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates (ADCs)
2) By Immunomodulators: Cytokines, Immune Checkpoint Modulators, Toll-Like Receptor Agonists, Immune Adjuvants
3) By Oncolytic Viral Therapies And Cancer Vaccines: Oncolytic Virus-Based Therapies, Cancer Vaccines, Viral Vectors For Immunotherapy
4) By Other Drug Types: Adoptive Cell Therapy, Immune Cell Modulators, Small Molecule Immune Modulators, Gene Editing And Immunotherapy For further insights on this market, request a sample here

North America was the largest region in the cancer immunotherapy drug discovery outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer immunotherapy drug discovery outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the cancer immunotherapy drug discovery outsourcing market are Thermo Fisher Scientific Inc., Danaher Corporation, Laboratory Corporation of America Holdings (LabCorp), Eurofins Scientific SE, WuXi AppTec Co Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Evotec SE, Shanghai ChemPartner Co. Ltd., Aragen Life Sciences Limited, GenScript Biotech Corporation, BGI Genomics Co. Ltd., NeoGenomics Laboratories Inc., ARUP Laboratories, Syngene International Limited, BioDuro-Sundia, Ambry Genetics Corporation, Selvita, Crown Bioscience International, CENTOGENE N.V., Jubilant Biosys, Oncodesign Services, Icagen Inc., Reaction Biology Corporation, ChemBridge Corporation . For further insights on this market, request a sample here.

Major trends in this market include Strategic Partnerships Driving Cancer Immunotherapy Drug Discovery Outsourcing. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Cancer Immunotherapy Drug Discovery Outsourcing Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top